Esmaeilzadeh Firooz, Mohammadi Masoud, Amjadipour Abolfazl, Jafari Alireza, Ghelichi-Ghojogh Mousa, Khezri Rozhan, Rajabi Abdolhalim
Department of Public Health, School of Public Health, Maragheh University of Medical Sciences, Maragheh, Iran.
Department of Golestan Research Centre of Gastroenterology and Hepatology, Golestan University of Medical Sciences, Gorgan, Iran.
Iran J Public Health. 2022 Jul;51(7):1513-1524. doi: 10.18502/ijph.v51i7.10085.
Syphilis is one of the most important sexually transmitted infections (STI) and a public health problem, but the literature describing the true burden of syphilis is limited. In Iran, there are no accurate results on the prevalence of syphilis. This study aimed to conduct a systematic review and meta-analysis of syphilis in Iran.
Following PRISMA guidelines, we conducted a systematic review and meta-analysis of studies published on the prevalence of Syphilis in Iran. We systematically reviewed the literature to identify eligible studies as of Sep 13, 2020, in international and national databases. The results are presented in the form of forest plots and tables. Pooled prevalence and 95% confidence intervals were calculated using Der Simonian and Laird method. Perform subgroup analysis through population, gender, city, and diagnostic tests to assess the source of heterogeneity.
We reviewed 1,229 papers and reports, and extracted data from 15 eligible records. The prevalence of combined syphilis in Iran is 0.1% (95% confidence interval [95% CI] 0.1-0.1%). The prevalence of syphilis was 0.4% in men (95% confidence interval [95% CI] -0.3, 1%) and 0.6% in women (95% confidence interval [95% CI] (0.1, 1%)). The cumulative meta-analysis showed a decline in the prevalence of syphilis between the years 1999 and 2015.
The prevalence of syphilis in Iran is low. In the past few decades, the prevalence of syphilis across the country has declined. Syphilis infection is a small burden that needs to be revised in the implementation of high-cost screening programs.
梅毒是最重要的性传播感染之一,也是一个公共卫生问题,但描述梅毒真实负担的文献有限。在伊朗,尚无关于梅毒患病率的准确结果。本研究旨在对伊朗的梅毒进行系统评价和荟萃分析。
遵循PRISMA指南,我们对发表在伊朗梅毒患病率的研究进行了系统评价和荟萃分析。我们系统地回顾了文献,以确定截至2020年9月13日在国际和国内数据库中的合格研究。结果以森林图和表格的形式呈现。使用Der Simonian和Laird方法计算合并患病率和95%置信区间。通过人群、性别、城市和诊断测试进行亚组分析,以评估异质性来源。
我们回顾了1229篇论文和报告,并从15条合格记录中提取了数据。伊朗梅毒合并患病率为0.1%(95%置信区间[95%CI]0.1 - 0.1%)。男性梅毒患病率为0.4%(95%置信区间[95%CI] - 0.3,1%),女性为0.6%(95%置信区间[95%CI](0.1,1%))。累积荟萃分析显示,1999年至2015年期间梅毒患病率呈下降趋势。
伊朗梅毒患病率较低。在过去几十年中,全国梅毒患病率有所下降。梅毒感染负担较小,在实施高成本筛查项目时需要重新评估。